The American Medical Informatics Association would like to see the National Institutes of Health consider different metrics to assess data quality and completeness when measuring the value of biomedical digital data repositories.
“In the era of precision medicine, biomedical data repositories are the lifeblood of clinical research,” said AMIA President and CEO Doug Fridsma, MD. “As we begin to re-engineer the clinical research enterprise, it will be critical to objectively differentiate between quality and inferior repositories.”
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access